Pandemic influenza vaccine H5N1 AstraZeneca, pandemijsko cjepivo protiv influence (H5N1) (živo, atenuirano, za nos)
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Pandemic influenza vaccine H5N1 AstraZeneca, pandemijsko cjepivo protiv influence (H5N1) (živo, atenuirano, za nos) |
|---|---|
| Former Name | Pandemic influenza vaccine H5N1 Medimmune |
| Active Substance | presloženi virus influence, soj A (H5N1), (živi, atenuirani) |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| ATC Code | J07BB03 |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
